Fundraising Fox

Pillar Biosciences

Natick, US · Delaware corporation · 1 known investors

pillarbiosci.com ↗

Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

SL
Shawn LiuNamed on SEC filing
HY
Hui YangNamed on SEC filing
GS
Gang SongNamed on SEC filing
ZW
Zhaohui WangNamed on SEC filing
RF
Robert ForresterNamed on SEC filing
HF
Hong Fang SongNamed on SEC filing
EL
Eric LaiNamed on SEC filing

Investors · 1

Catalio Capital Management, LPNew York

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2021

▶$20MraisedJun 2021 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawn LiuDirector
  • Hui YangDirector
  • Gang SongExecutive Officer, Director
  • Zhaohui WangDirector
  • Robert ForresterDirector
  • Hong Fang SongDirector
  • Eric LaiDirector
Offering amount
$50.6M
Amount sold
$20M
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
IQVIA58 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Precision BioSciences56 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Genomeweb47 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Fortis Life Sciences46 shared keywordsFortis Life Sciences develops and manufactures immunodetection reagents including primary and secondary antibodies, ELISA kits, antigens, engineered nanoparticles, and VHH single-domain antibody libraries. It supplies biopharma, diagnostics, research, and applied technology customers globally from North American manufacturing and R&D sites.

Companies competing with Pillar Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Pillar Biosciences do?
Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Who are Pillar Biosciences's investors?
Pillar Biosciences's investors include Catalio Capital Management, LP.
How much funding has Pillar Biosciences raised?
Pillar Biosciences has disclosed $20M raised across 1 round.
Where is Pillar Biosciences headquartered?
Pillar Biosciences is headquartered in Natick, US.